Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial

  • Mathias Witzens-Harig, Axel Benner, Fabienne McClanahan, Jennifer Klemmer, Julia Brandt, Elke Brants, Michael Rieger, Julia Meissner, Manfred Hensel, Kai Neben, Peter Dreger, Eva Lengfelder, Ingo Schmidt-Wolf, Alwin Krämer, Anthony D. Ho
  • British Journal of Haematology, October 2015, Wiley
  • DOI: 10.1111/bjh.13652

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/bjh.13652

In partnership with: